Mikhail Blagosklonny; One Of The Best Oncology Scientist In The World

Currently acting as the Oncology Professor at Roswell Park Centre Institute, Mikhail Blagosklonny is one individual who has contributed a lot in the healthcare industry. After seeing how cancer kills a lot of people regardless of the age, Mikhail decided to spend most of his time trying to figure out a way out of this disaster. Being a scientist who studies aging and cancer, Mikhail has been able to earn respect from other scientist considering his numerous achievements and contributions.

Mikhail was once a student at the First Pavlov state Medical University where he graduated with an MD in Internal Medicine. He later decided to further his studies at the same university to earn a Ph.D. in cardiology and Experimental Medicine. Mikhail believed that for him to find a way out if aging and cancer, he first had to acquire an education and this is what he did. As a scientist, he had to gain the right amount of experience to put his theoretical knowledge to test. Follow Mikhail on Google Scholar

This led to him working at the New York Medical College as an associate professor before he joined Ordway Research Institute as a senior scientist. He worked at Ordway for some years before joining Roswell Institute. Through working in these institutions, Mikhail Blagosklonny has been able to sharpen his skills to become an excellent scientist and professor. As a scientist, Blagosklonny enjoys researching on cancer therapies, anti-aging drugs, and most importantly cancer.

From what he has researched, Mikhail came up with a hypothesis on how cancer can be cured. He advocates that with the use of Rapamycin with conjunction with TOR signaling, cancer can be cured. Blagosklonny continuously advocates on the usage of the Rapamycin from what he has learned from his research he has conducted for many years.

Blagosklonny associates cancer as an age-related disease, and this is why he argues that through reducing or stopping the aging process, all age-related diseases can be prevented. He gets a chance to share what he learns from his research through his various publications. He is actively involved in the media industry as he also acts an associate editor and editor in chief of different journals mostly those that talk about oncology. He hopes that he will one day find a way out of this disaster and help the human race. Visit classroomvoices.org to read more about Mikhail.

Oncotarget is On Target

Oncotarget, a peer reviewed medical journal, offers more than just cutting edge information on the art of oncology. It provides access to a knowledge sharing community, one that aims to make the world a healthier and safer place. They say that knowledge is power, and Oncotarget certainly embodies this statement. Professionals on Twitter can read and submit quality papers and articles at the touch of a button. Since 2010, in fact, 370 papers on oxygen oncology topics have been published. This show the plethora of research that has been explored via Oncotarget within the last almost decade.

Editors in chief Andrei V Gudkov and Mikhail V Blagosklonny of the Roswell Cancer Institute over in Buffalo, New York, both stress the importance of having an impact on the world around us. This idea of having an impact is professed throughout their website. In addition, Oncotarget has a tremendous social media presence on Endnote.com. You can find them on Twitter, YouTube, Facebook, Google Plus and LinkedIn. This, again, empowers the individual to continue to research and explore topics in oncology.

Oncotarget stresses the concept of ethics, and each article submitted must go through a rigorous review process. You can find credible articles in their archives, as well as write your own through submitting through the portal located on the very left of the screen. Oncotarget explores topics that stem from oncology, but are not necessarily the main focus on DovePress. For example, scrolling down, you can find articles about aging, immunology/microbiology, chromosome studies, and studies involving cell death.

Oncotarget, in addition to being interactive, has employment opportunities listed front and center. This shows the importance put into professional development of clinicians, as well as the value Oncotarget places on those who use the site. It is just as simple to get in touch with the editor, and you can do so with a simple e-mail. Source: https://www.linkedin.com/company/oncotarget